{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T16:50:58Z","timestamp":1745859058998,"version":"3.37.3"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["669026","763781","669026","763781","669026","763781","669026","763781"],"award-info":[{"award-number":["669026","763781","669026","763781","669026","763781","669026","763781"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Variants of unknown\/uncertain significance (VUS) pose a huge dilemma in current genetic variation screening methods and genetic counselling. Driven by methods of next generation sequencing (NGS) such as whole exome sequencing (WES), a plethora of VUS are being detected in research laboratories as well as in the health sector. Motivated by this overabundance of VUS, we propose a novel computational methodology, termed VariantClassifier (VarClass), which utilizes gene-association networks and polygenic risk prediction models to shed light into this grey area of genetic variation in association with disease. VarClass has been evaluated using numerous validation steps and proves to be very successful in assigning significance to VUS in association with specific diseases of interest. Notably, using VUS that are deemed significant by VarClass, we improved risk prediction accuracy in four large case-studies involving disease-control cohorts from GWAS as well as WES, when compared to traditional odds ratio analysis. Biological interpretation of selected high scoring VUS revealed interesting biological themes relevant to the diseases under investigation. VarClass is available as a standalone tool for large-scale data analyses, as well as a web-server with additional functionalities through a user-friendly graphical interface.<\/jats:p>","DOI":"10.1038\/s41598-019-39796-w","type":"journal-article","created":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T11:06:43Z","timestamp":1551438403000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Selecting variants of unknown significance through network-based gene-association significantly improves risk prediction for disease-control cohorts"],"prefix":"10.1038","volume":"9","author":[{"given":"Anastasis","family":"Oulas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Minadakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarita","family":"Zachariou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2470-3363","authenticated-orcid":false,"given":"George M.","family":"Spyrou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,1]]},"reference":[{"issue":"Suppl 8","key":"39796_CR1","doi-asserted-by":"publisher","first-page":"viii69","DOI":"10.1093\/annonc\/mdt312","volume":"24","author":"S Richter","year":"2013","unstructured":"Richter, S. et al. Variants of unknown significance in BRCA testing: impact on risk perception, worry, prevention and counseling. Ann Oncol 24(Suppl 8), viii69\u2013viii74 (2013).","journal-title":"Ann Oncol"},{"key":"39796_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-014-0121-3","volume":"6","author":"JY Cheon","year":"2014","unstructured":"Cheon, J. Y., Mozersky, J. & Cook-Deegan, R. Variants of uncertain significance in BRCA: a harbinger of ethical and policy issues to come? Genome Med 6, 121 (2014).","journal-title":"Genome Med"},{"key":"39796_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/srep07953","volume":"5","author":"O Campuzano","year":"2015","unstructured":"Campuzano, O., Allegue, C., Fernandez, A., Iglesias, A. & Brugada, R. Determining the pathogenicity of genetic variants associated with cardiac channelopathies. Sci Rep 5, 7953 (2015).","journal-title":"Sci Rep"},{"key":"39796_CR4","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1309\/LMWZH57BRWOPR5RQ","volume":"46","author":"WL Schulz","year":"2015","unstructured":"Schulz, W. L., Tormey, C. A. & Torres, R. Computational Approach to Annotating Variants of Unknown Significance in Clinical Next Generation Sequencing. Lab Med 46, 285\u20139 (2015).","journal-title":"Lab Med"},{"key":"39796_CR5","doi-asserted-by":"publisher","first-page":"408","DOI":"10.4143\/crt.2016.135","volume":"49","author":"KJ Eoh","year":"2017","unstructured":"Eoh, K. J. et al. Comparison of Clinical Outcomes of BRCA1\/2 Pathologic Mutation, Variants of Unknown Significance, or Wild Type Epithelial Ovarian Cancer Patients. Cancer Res Treat 49, 408\u2013415 (2017).","journal-title":"Cancer Res Treat"},{"key":"39796_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00702-014-1341-9","volume":"122","author":"E Cocchi","year":"2015","unstructured":"Cocchi, E., Drago, A., Fabbri, C. & Serretti, A. A model to investigate SNPs\u2019 interaction in GWAS studies. J Neural Transm (Vienna) 122, 145\u201353 (2015).","journal-title":"J Neural Transm (Vienna)"},{"key":"39796_CR7","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/nrg4017","volume":"16","author":"AR Harper","year":"2015","unstructured":"Harper, A. R., Nayee, S. & Topol, E. J. Protective alleles and modifier variants in human health and disease. Nat Rev Genet 16, 689\u2013701 (2015).","journal-title":"Nat Rev Genet"},{"key":"39796_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-017-3964-3","volume":"18","author":"JM Butler","year":"2017","unstructured":"Butler, J. M., Hall, N., Narendran, N., Yang, Y. C. & Paraoan, L. Identification of candidate protective variants for common diseases and evaluation of their protective potential. BMC Genomics 18, 575 (2017).","journal-title":"BMC Genomics"},{"key":"39796_CR9","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.jid.2015.12.007","volume":"136","author":"KP Kypreou","year":"2016","unstructured":"Kypreou, K. P. et al. Prediction of Melanoma Risk in a Southern European Population Based on a Weighted Genetic Risk Score. J Invest Dermatol 136, 690\u20135 (2016).","journal-title":"J Invest Dermatol"},{"key":"39796_CR10","doi-asserted-by":"publisher","first-page":"520","DOI":"10.4103\/1008-682X.179527","volume":"18","author":"CA Conran","year":"2016","unstructured":"Conran, C. A. et al. Population-standardized genetic risk score: the SNP-based method of choice for inherited risk assessment of prostate cancer. Asian J Androl 18, 520\u20134 (2016).","journal-title":"Asian J Androl"},{"key":"39796_CR11","doi-asserted-by":"publisher","first-page":"e1003153","DOI":"10.1371\/journal.pcbi.1003153","volume":"9","author":"U Paila","year":"2013","unstructured":"Paila, U., Chapman, B. A., Kirchner, R. & Quinlan, A. R. GEMINI: integrative exploration of genetic variation and genome annotations. PLoS Comput Biol 9, e1003153 (2013).","journal-title":"PLoS Comput Biol"},{"key":"39796_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature11247","volume":"489","author":"EP Consortium","year":"2012","unstructured":"Consortium, E. P. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57\u201374 (2012).","journal-title":"Nature"},{"key":"39796_CR13","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1101\/gr.229102","volume":"12","author":"WJ Kent","year":"2002","unstructured":"Kent, W. J. et al. The human genome browser at UCSC. Genome Res 12, 996\u20131006 (2002).","journal-title":"Genome Res"},{"key":"39796_CR14","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11357-008-9063-2","volume":"31","author":"LA Christie","year":"2009","unstructured":"Christie, L. A., Opii, W. O. & Head, E. Strategies for improving cognition with aging: insights from a longitudinal study of antioxidant and behavioral enrichment in canines. Age (Dordr) 31, 211\u201320 (2009).","journal-title":"Age (Dordr)"},{"key":"39796_CR15","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/nar\/29.1.308","volume":"29","author":"ST Sherry","year":"2001","unstructured":"Sherry, S. T. et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 29, 308\u201311 (2001).","journal-title":"Nucleic Acids Res"},{"key":"39796_CR16","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"M Kanehisa","year":"2017","unstructured":"Kanehisa, M., Furumichi, M., Tanabe, M., Sato, Y. & Morishima, K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res 45, D353\u2013D361 (2017).","journal-title":"Nucleic Acids Res"},{"key":"39796_CR17","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/978-1-60761-232-2_6","volume":"577","author":"TS Prasad","year":"2009","unstructured":"Prasad, T. S., Kandasamy, K. & Pandey, A. Human Protein Reference Database and Human Proteinpedia as discovery tools for systems biology. Methods Mol Biol 577, 67\u201379 (2009).","journal-title":"Methods Mol Biol"},{"key":"39796_CR18","doi-asserted-by":"publisher","first-page":"D840","DOI":"10.1093\/nar\/gkw971","volume":"45","author":"KJ Karczewski","year":"2017","unstructured":"Karczewski, K. J. et al. The ExAC browser: displaying reference data information from over 60 000 exomes. Nucleic Acids Res 45, D840\u2013D845 (2017).","journal-title":"Nucleic Acids Res"},{"key":"39796_CR19","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/pmic.200900810","volume":"11","author":"NV Bykova","year":"2011","unstructured":"Bykova, N. V. et al. Redox-sensitive proteome and antioxidant strategies in wheat seed dormancy control. Proteomics 11, 865\u201382 (2011).","journal-title":"Proteomics"},{"key":"39796_CR20","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"C Genomes Project","year":"2015","unstructured":"Genomes Project, C. et al. A global reference for human genetic variation. Nature 526, 68\u201374 (2015).","journal-title":"Nature"},{"key":"39796_CR21","doi-asserted-by":"publisher","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","volume":"46","author":"MJ Landrum","year":"2018","unstructured":"Landrum, M. J. et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res 46, D1062\u2013D1067 (2018).","journal-title":"Nucleic Acids Res"},{"key":"39796_CR22","doi-asserted-by":"publisher","first-page":"D777","DOI":"10.1093\/nar\/gkw1121","volume":"45","author":"SA Forbes","year":"2017","unstructured":"Forbes, S. A. et al. COSMIC: somatic cancer genetics at high-resolution. Nucleic Acids Res 45, D777\u2013D783 (2017).","journal-title":"Nucleic Acids Res"},{"key":"39796_CR23","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ng.2892","volume":"46","author":"M Kircher","year":"2014","unstructured":"Kircher, M. et al. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet 46, 310\u20135 (2014).","journal-title":"Nat Genet"},{"key":"39796_CR24","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei, I. A. et al. A method and server for predicting damaging missense mutations. Nat Methods 7, 248\u20139 (2010).","journal-title":"Nat Methods"},{"key":"39796_CR25","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/nprot.2009.86","volume":"4","author":"P Kumar","year":"2009","unstructured":"Kumar, P., Henikoff, S. & Ng, P. C. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 4, 1073\u201381 (2009).","journal-title":"Nat Protoc"},{"key":"39796_CR26","doi-asserted-by":"crossref","unstructured":"Arbustini, E. et al. RE: BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. J Natl Cancer Inst 108 (2016).","DOI":"10.1093\/jnci\/djw172"},{"key":"39796_CR27","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/ng.2416","volume":"44","author":"R Cowper-Sal lari","year":"2012","unstructured":"Cowper-Sal lari, R. et al. Breast cancer risk-associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression. Nat Genet 44, 1191\u20138 (2012).","journal-title":"Nat Genet"},{"key":"39796_CR28","doi-asserted-by":"crossref","unstructured":"Meeks, H. D. et al. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. J Natl Cancer Inst 108 (2016).","DOI":"10.1093\/jnci\/djw172"},{"key":"39796_CR29","first-page":"369","volume":"30","author":"A Mehrgou","year":"2016","unstructured":"Mehrgou, A. & Akouchekian, M. The importance of BRCA1 and BRCA2 genes mutations in breast cancer development. Med J Islam Repub Iran 30, 369 (2016).","journal-title":"Med J Islam Repub Iran"},{"key":"39796_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-017-0489-y","volume":"9","author":"CM Lewis","year":"2017","unstructured":"Lewis, C. M. & Vassos, E. Prospects for using risk scores in polygenic medicine. Genome Med 9, 96 (2017).","journal-title":"Genome Med"},{"key":"39796_CR31","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1086\/521878","volume":"81","author":"P Chanda","year":"2007","unstructured":"Chanda, P. et al. Information-theoretic metrics for visualizing gene-environment interactions. Am J Hum Genet 81, 939\u201363 (2007).","journal-title":"Am J Hum Genet"},{"key":"39796_CR32","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1093\/hmg\/11.20.2463","volume":"11","author":"HJ Cordell","year":"2002","unstructured":"Cordell, H. J. Epistasis: what it means, what it doesn\u2019t mean, and statistical methods to detect it in humans. Hum Mol Genet 11, 2463\u20138 (2002).","journal-title":"Hum Mol Genet"},{"key":"39796_CR33","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1093\/bioinformatics\/btf869","volume":"19","author":"LW Hahn","year":"2003","unstructured":"Hahn, L. W., Ritchie, M. D. & Moore, J. H. Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 19, 376\u201382 (2003).","journal-title":"Bioinformatics"},{"key":"39796_CR34","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/msb4100124","volume":"3","author":"D Anastassiou","year":"2007","unstructured":"Anastassiou, D. Computational analysis of the synergy among multiple interacting genes. Mol Syst Biol 3, 83 (2007).","journal-title":"Mol Syst Biol"},{"key":"39796_CR35","doi-asserted-by":"publisher","first-page":"W444","DOI":"10.1093\/nar\/gkr321","volume":"39","author":"T Curk","year":"2011","unstructured":"Curk, T., Rot, G. & Zupan, B. SNPsyn: detection and exploration of SNP-SNP interactions. Nucleic Acids Res 39, W444\u20139 (2011).","journal-title":"Nucleic Acids Res"},{"key":"39796_CR36","doi-asserted-by":"publisher","first-page":"W214","DOI":"10.1093\/nar\/gkq537","volume":"38","author":"D Warde-Farley","year":"2010","unstructured":"Warde-Farley, D. et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res 38, W214\u201320 (2010).","journal-title":"Nucleic Acids Res"},{"key":"39796_CR37","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/sim.4348","volume":"31","author":"MJ Pencina","year":"2012","unstructured":"Pencina, M. J., D\u2019Agostino, R. B. Sr. & Demler, O. V. Novel metrics for evaluating improvement in discrimination: net reclassification and integrated discrimination improvement for normal variables and nested models. Stat Med 31, 101\u201313 (2012).","journal-title":"Stat Med"},{"key":"39796_CR38","doi-asserted-by":"publisher","first-page":"135","DOI":"10.4161\/cbt.7.1.5199","volume":"7","author":"AC Tan","year":"2008","unstructured":"Tan, A. C. et al. Allele-specific expression in the germline of patients with familial pancreatic cancer: an unbiased approach to cancer gene discovery. Cancer Biol Ther 7, 135\u201344 (2008).","journal-title":"Cancer Biol Ther"},{"key":"39796_CR39","first-page":"1","volume":"0","author":"X Yi","year":"2014","unstructured":"Yi, X. & Jixiang, W. linkim: Linkage information based genotype imputation method. R package version 0, 1 (2014).","journal-title":"R package version"},{"key":"39796_CR40","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1089\/bio.2015.29031.hmm","volume":"13","author":"LJ Carithers","year":"2015","unstructured":"Carithers, L. J. & Moore, H. M. The Genotype-Tissue Expression (GTEx) Project. Biopreserv Biobank 13, 307\u20138 (2015).","journal-title":"Biopreserv Biobank"},{"key":"39796_CR41","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/jpm5010022","volume":"5","author":"JC Keen","year":"2015","unstructured":"Keen, J. C. & Moore, H. M. The Genotype-Tissue Expression (GTEx) Project: Linking Clinical Data with Molecular Analysis to Advance Personalized Medicine. J Pers Med 5, 22\u20139 (2015).","journal-title":"J Pers Med"},{"key":"39796_CR42","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","author":"GT Consortium","year":"2013","unstructured":"Consortium, G. T. The Genotype-Tissue Expression (GTEx) project. Nat Genet 45, 580\u20135 (2013).","journal-title":"Nat Genet"},{"key":"39796_CR43","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/2045-8118-9-23","volume":"9","author":"AC Luissint","year":"2012","unstructured":"Luissint, A. C., Artus, C., Glacial, F., Ganeshamoorthy, K. & Couraud, P. O. Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulation. Fluids Barriers CNS 9, 23 (2012).","journal-title":"Fluids Barriers CNS"},{"key":"39796_CR44","doi-asserted-by":"publisher","first-page":"543673","DOI":"10.1155\/2014\/543673","volume":"2014","author":"BR Corradini","year":"2014","unstructured":"Corradini, B. R. et al. Complex network-driven view of genomic mechanisms underlying Parkinson\u2019s disease: analyses in dorsal motor vagal nucleus, locus coeruleus, and substantia nigra. Biomed Res Int 2014, 543673 (2014).","journal-title":"Biomed Res Int"},{"key":"39796_CR45","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.tig.2011.02.004","volume":"27","author":"SM Hammond","year":"2011","unstructured":"Hammond, S. M. & Wood, M. J. Genetic therapies for RNA mis-splicing diseases. Trends Genet 27, 196\u2013205 (2011).","journal-title":"Trends Genet"},{"key":"39796_CR46","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1038\/emboj.2012.170","volume":"31","author":"N Exner","year":"2012","unstructured":"Exner, N., Lutz, A. K., Haass, C. & Winklhofer, K. F. Mitochondrial dysfunction in Parkinson\u2019s disease: molecular mechanisms and pathophysiological consequences. EMBO J 31, 3038\u201362 (2012).","journal-title":"EMBO J"},{"key":"39796_CR47","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00401-011-0902-3","volume":"123","author":"A Pilsl","year":"2012","unstructured":"Pilsl, A. & Winklhofer, K. F. Parkin, PINK1 and mitochondrial integrity: emerging concepts of mitochondrial dysfunction in Parkinson\u2019s disease. Acta Neuropathol 123, 173\u201388 (2012).","journal-title":"Acta Neuropathol"},{"key":"39796_CR48","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bbadis.2009.08.013","volume":"1802","author":"KF Winklhofer","year":"2010","unstructured":"Winklhofer, K. F. & Haass, C. Mitochondrial dysfunction in Parkinson\u2019s disease. Biochim Biophys Acta 1802, 29\u201344 (2010).","journal-title":"Biochim Biophys Acta"},{"key":"39796_CR49","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhlen","year":"2015","unstructured":"Uhlen, M. et al. Proteomics. Tissue-based map of the human proteome. Science 347, 1260419 (2015).","journal-title":"Science"},{"key":"39796_CR50","doi-asserted-by":"publisher","first-page":"508","DOI":"10.4161\/nucl.36360","volume":"5","author":"A Curinha","year":"2014","unstructured":"Curinha, A., Oliveira Braz, S., Pereira-Castro, I., Cruz, A. & Moreira, A. Implications of polyadenylation in health and disease. Nucleus 5, 508\u201319 (2014).","journal-title":"Nucleus"},{"key":"39796_CR51","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/mds.26374","volume":"31","author":"MA Nalls","year":"2016","unstructured":"Nalls, M. A. et al. Baseline genetic associations in the Parkinson\u2019s Progression Markers Initiative (PPMI). Mov Disord 31, 79\u201385 (2016).","journal-title":"Mov Disord"},{"key":"39796_CR52","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S1474-4422(15)00178-7","volume":"14","author":"MA Nalls","year":"2015","unstructured":"Nalls, M. A. et al. Diagnosis of Parkinson\u2019s disease on the basis of clinical and genetic classification: a population-based modelling study. Lancet Neurol 14, 1002\u20139 (2015).","journal-title":"Lancet Neurol"},{"key":"39796_CR53","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1086\/507471","volume":"79","author":"JM Friedman","year":"2006","unstructured":"Friedman, J. M. et al. Oligonucleotide microarray analysis of genomic imbalance in children with mental retardation. Am J Hum Genet 79, 500\u201313 (2006).","journal-title":"Am J Hum Genet"},{"key":"39796_CR54","doi-asserted-by":"publisher","first-page":"6787648","DOI":"10.1155\/2016\/6787648","volume":"2016","author":"D Satge","year":"2016","unstructured":"Satge, D., Kempf, E., Dubois, J. B., Nishi, M. & Tredaniel, J. Challenges in Diagnosis and Treatment of Lung Cancer in People with Intellectual Disabilities: Current State of Knowledge. Lung Cancer Int 2016, 6787648 (2016).","journal-title":"Lung Cancer Int"},{"key":"39796_CR55","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1111\/j.1469-8749.1982.tb13702.x","volume":"24","author":"T Scholl","year":"1982","unstructured":"Scholl, T., Stein, Z. & Hansen, H. Leukemia and other cancers, anomalies and infections as causes of death in Down\u2019s syndrome in the United States during 1976. Dev Med Child Neurol 24, 817\u201329 (1982).","journal-title":"Dev Med Child Neurol"},{"key":"39796_CR56","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1002\/ijc.21518","volume":"118","author":"K Patja","year":"2006","unstructured":"Patja, K., Pukkala, E., Sund, R., Iivanainen, M. & Kaski, M. Cancer incidence of persons with Down syndrome in Finland: a population-based study. Int J Cancer 118, 1769\u201372 (2006).","journal-title":"Int J Cancer"},{"key":"39796_CR57","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/gim.2016.23","volume":"18","author":"H Hasle","year":"2016","unstructured":"Hasle, H., Friedman, J. M., Olsen, J. H. & Rasmussen, S. A. Low risk of solid tumors in persons with Down syndrome. Genet Med 18, 1151\u20131157 (2016).","journal-title":"Genet Med"},{"key":"39796_CR58","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/j.1365-2788.2006.00862.x","volume":"51","author":"SG Sullivan","year":"2007","unstructured":"Sullivan, S. G., Hussain, R., Glasson, E. J. & Bittles, A. H. The profile and incidence of cancer in Down syndrome. J Intellect Disabil Res 51, 228\u201331 (2007).","journal-title":"J Intellect Disabil Res"},{"key":"39796_CR59","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1001\/archinte.163.6.705","volume":"163","author":"DA Hill","year":"2003","unstructured":"Hill, D. A. et al. Mortality and cancer incidence among individuals with Down syndrome. Arch Intern Med 163, 705\u201311 (2003).","journal-title":"Arch Intern Med"},{"key":"39796_CR60","first-page":"609","volume":"57","author":"E de Graaff","year":"1995","unstructured":"de Graaff, E. et al. Instability of the CGG repeat and expression of the FMR1 protein in a male fragile X patient with a lung tumor. Am J Hum Genet 57, 609\u201318 (1995).","journal-title":"Am J Hum Genet"},{"key":"39796_CR61","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1365-2788.2008.01116.x","volume":"53","author":"R Sund","year":"2009","unstructured":"Sund, R., Pukkala, E. & Patja, K. Cancer incidence among persons with fragile X syndrome in Finland: a population-based study. J Intellect Disabil Res 53, 85\u201390 (2009).","journal-title":"J Intellect Disabil Res"},{"key":"39796_CR62","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1002\/emmm.201302847","volume":"5","author":"R Luca","year":"2013","unstructured":"Luca, R. et al. The fragile X protein binds mRNAs involved in cancer progression and modulates metastasis formation. EMBO Mol Med 5, 1523\u201336 (2013).","journal-title":"EMBO Mol Med"},{"key":"39796_CR63","unstructured":"Csardi, G. & Nepusz, T. The igraph software package for complex network research. Inter Journal Complex Systems (2006)."},{"key":"39796_CR64","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s10654-011-9567-4","volume":"26","author":"S Kundu","year":"2011","unstructured":"Kundu, S., Aulchenko, Y. S., van Duijn, C. M. & Janssens, A. C. PredictABEL: an R package for the assessment of risk prediction models. Eur J Epidemiol 26, 261\u20134 (2011).","journal-title":"Eur J Epidemiol"},{"key":"39796_CR65","first-page":"9","volume":"1","author":"A Gelman","year":"2016","unstructured":"Gelman, A. & Su, Y. Arm: Data Analysis Using Regression and Multilevel\/Hierarchical Models. R package version 1, 9\u20133 (2016).","journal-title":"R package version"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-39796-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-39796-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-39796-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T06:57:58Z","timestamp":1671260278000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-39796-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,1]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["39796"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-39796-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2019,3,1]]},"assertion":[{"value":"17 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"3266"}}